Company intelligence / Profile preview

Chengdu Jinkai Biotechnology

Ownership: Private
Development stage: Other

Overview

Chengdu Jinkai Biotechnology is a Chinese biopharmaceutical company focused on the research, development, and industrialization of recombinant protein vaccines and therapeutic biologics. The company leverages its proprietary high-efficiency protein expression and purification platforms to target infectious diseases and oncology. Its pipeline includes several high-value vaccine candidates, such as those for Human Papillomavirus (HPV) and Herpes Simplex Virus (HSV). Based in the Chengdu Medical City, the firm aims to provide affordable, high-quality biological products for global health challenges.

Therapeutic areas: OncologyInfectious Diseases
Modalities: Recombinant proteinVaccineMonoclonal antibody
Industry: Biotech

Beyond the preview

Go deeper on Chengdu Jinkai Biotechnology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Chengdu Jinkai Biotechnology.